1-4 of 4
Clayton Smith
Close
Sort by
Journal Articles

Frontline chemoimmunotherapy with nivolumab and dose-adjusted EPOCH in peripheral T-cell lymphoma: a phase 1 trial

Clinical Trials & Observations
Bradley Haverkos, Jasmine Zain, Manali Kamdar, Alexander Neuwelt, Eduardo Davila, Xander Bradeen, Ajay Major, Steven Bair, Jagar Jasem, Clayton Smith, Diana Abbott, Pierluigi Porcu
Journal: Blood Advances
Blood Adv (2024) 8 (3): 708–711.
https://doi.org/10.1182/bloodadvances.2023011526
Published: 2024
Journal Articles

Venetoclax and azacitidine compared with induction chemotherapy for newly diagnosed patients with acute myeloid leukemia

Clinical Trials & Observations
Evan M. Cherry, Diana Abbott, Maria Amaya, Christine McMahon, Marc Schwartz, Julie Rosser, Audrey Sato, Jeffrey Schowinsky, Anagha Inguva, Mohd Minhajuddin, Shanshan Pei, Brett Stevens, Amanda Winters, Craig T. Jordan, Clayton Smith, Jonathan A. Gutman, Daniel A. Pollyea
Journal: Blood Advances
Blood Adv (2021) 5 (24): 5565–5573.
https://doi.org/10.1182/bloodadvances.2021005538
Published: 2021
Includes: Supplemental data
Journal Articles

Glasdegib as maintenance therapy for patients with AML and MDS patients at high risk for postallogeneic stem cell transplant relapse

Clinical Trials & Observations
Andrew Kent, Sumithira Vasu, Derek Schatz, Natalie Monson, Steven Devine, Clayton Smith, Jonathan A. Gutman, Daniel A. Pollyea
Journal: Blood Advances
Blood Adv (2020) 4 (13): 3102–3108.
https://doi.org/10.1182/bloodadvances.2020001991
Published: 2020
Includes: Supplemental data
Journal Articles

Real-world experience of venetoclax with azacitidine for untreated patients with acute myeloid leukemia

Clinical Trials & Observations
Amanda C. Winters, Jonathan A. Gutman, Enkhtsetseg Purev, Molly Nakic, Jennifer Tobin, Stephanie Chase, Jeff Kaiser, Lindsey Lyle, Chelsey Boggs, Keri Halsema, Jeffrey T. Schowinsky, Julie Rosser, Mark D. Ewalt, Bradford Siegele, Vishal Rana, Steven Schuster, Diana Abbott, Brett M. Stevens, Craig T. Jordan, Clayton Smith, Daniel A. Pollyea
Journal: Blood Advances
Blood Adv (2019) 3 (20): 2911–2919.
https://doi.org/10.1182/bloodadvances.2019000243
Published: 2019
Includes: Supplemental data